Literature DB >> 30231404

Breast Cancer in Latin America: A Map of the Disease in the Region.

Eduardo Cazap1.   

Abstract

In the next few decades, breast cancer will become a leading global public health problem as it increases disproportionately in low- and middle-income countries. Disparities are clear when comparisons are made with rates in Europe and the United States, but they also exist between the countries of the region or even within the same country in Latin America. Large cities or urban areas have better access and resource availability than small towns or remote zones. This article presents the status of the disease across 12 years with data obtained through three studies performed in 2006, 2010, and 2013 and based on surveys, reviews of literature, patient organizations, and public databases. The first study provided a general picture of breast cancer control in the region (Latin America); the second compared expert perceptions with medical care standards; and the third was a review of literature and public databases together with surveys of breast cancer experts and patient organizations. We conclude that breast cancer is the most frequent cancer and kills more women than any other cancer; we also suggest that aging is the principal risk factor, which will drive the incidence to epidemic levels as a result of demographic transition in Latin America. The economic burden also is large and can be clearly observed: in countries that today allocate insufficient resources, women go undiagnosed or uncared for or receive treatment with suboptimal therapies, all of which results in high morbidity and the associated societal costs. The vast inequities in access to health care in countries translates into unequal results in outcomes. National cancer control plans are the fundamental building block to an organized governance, financing, and delivery of health care for breast cancer.

Entities:  

Mesh:

Year:  2018        PMID: 30231404     DOI: 10.1200/EDBK_201315

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN: 1548-8748


  12 in total

1.  Perinatal factors, female breast cancer, and associated risk factors in Puerto Rico: evidence from the Atabey epidemiology of breast cancer study.

Authors:  Lindsey J Mattick; Cruz M Nazario; Rosa V Rosario-Rosado; Michelle Schelske-Santos; Imar Mansilla-Rivera; Farah A Ramírez-Marrero; Jing Nie; Jo L Freudenheim
Journal:  Cancer Causes Control       Date:  2022-01-09       Impact factor: 2.506

Review 2.  Breast cancer in low-middle income countries: abnormality in splicing and lack of targeted treatment options.

Authors:  Flavia Zita Francies; Rodney Hull; Richard Khanyile; Zodwa Dlamini
Journal:  Am J Cancer Res       Date:  2020-05-01       Impact factor: 5.942

3.  Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis.

Authors:  Lívia Lovato Pires de Lemos; Mirian Carvalho de Souza; Daniela Pena Moreira; Paulo Henrique Ribeiro Fernandes Almeida; Brian Godman; Stéphane Verguet; Augusto Afonso Guerra; Mariangela Leal Cherchiglia
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

4.  Screening of Prognostic Factors in Early-Onset Breast Cancer.

Authors:  Zhun Yu; Qi He; Guoping Xu
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115).

Authors:  Maria Alice Franzoi; Daniela D Rosa; Facundo Zaffaroni; Gustavo Werutsky; Sérgio Simon; José Bines; Carlos Barrios; Eduardo Cronemberger; Geraldo Silva Queiroz; Vladmir Cordeiro de Lima; Ruffo Freitas Júnior; José Couto; Karla Emerenciano; Heloísa Resende; Susanne Crocamo; Tomás Reinert; Brigitte Van Eyli; Yeni Nerón; Vanessa Dybal; Nicolas Lazaretti; Rita de Cassia Costamillan; Diocésio Alves Pinto de Andrade; Clarissa Mathias; Giovana Zerwes Vacaro; Giuliano Borges; Alessandra Morelle; Carlos Alberto Sampaio Filho; Max Mano; Pedro E R Liedke
Journal:  J Glob Oncol       Date:  2019-11

6.  Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America.

Authors:  Henry L Gomez; Juan E Bargallo-Rocha; Roberto J Billinghurst; Aníbal R Núñez De Pierro; Federico A Coló; Lisandro L B Gil; Carola Allemand; Ignacio L McLean; Mauricio Lema-Medina; Fernando Herazo-Maya; Francisco J Terrier; Raquel G Cwilich; Mauricio Leon; Silvia G Falcon; Roberto E Castaño; Sergio C Oliveira; Debbie M Jakubowski; Calvin Chao
Journal:  JCO Glob Oncol       Date:  2021-08

7.  Gynaecological cancer in Caribbean women: data from the French population-based cancer registries of Martinique, Guadeloupe and French Guiana (2007-2014).

Authors:  Clarisse Joachim; Jacqueline Véronique-Baudin; Laure Desroziers; Édouard Chatignoux; Sophie Belliardo; Juliette Plenet; Jonathan Macni; Stephen Ulric-Gervaise; Jessica Peruvien; Bernard Bhakkan-Mambir; Jacqueline Deloumeaux
Journal:  BMC Cancer       Date:  2020-07-10       Impact factor: 4.430

8.  Years of Potential Life Lost Because of Breast and Cervical Cancers in Guatemala.

Authors:  Alba J Kihn-Alarcón; Juan F Alvarado-Muñoz; Loida I Orozco-Fuentes; Erwin Calgua-Guerra; Vicky Fuentes-de Falla; Angel Velarde
Journal:  JCO Glob Oncol       Date:  2020-05

Review 9.  Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy.

Authors:  Laura Keren Urbina-Jara; Augusto Rojas-Martinez; Emmanuel Martinez-Ledesma; Dione Aguilar; Cynthia Villarreal-Garza; Rocio Ortiz-Lopez
Journal:  Genes (Basel)       Date:  2019-10-10       Impact factor: 4.096

10.  Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.

Authors:  Na Li; Yujiao Deng; Linghui Zhou; Tian Tian; Si Yang; Ying Wu; Yi Zheng; Zhen Zhai; Qian Hao; Dingli Song; Dai Zhang; Huafeng Kang; Zhijun Dai
Journal:  J Hematol Oncol       Date:  2019-12-21       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.